IMR Press / CEOG / Volume 46 / Issue 5 / DOI: 10.12891/ceog4804.2019

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Open Access Original Research
The predictive value of metabolic syndrome in the evaluation of pregnancy course and outcome
Show Less
1 Hospital for Gynecology and Obstetrics, University Center zvezdara, Belgrade, Serbia
2 High Health School of Professional Studies, University of Belgrade, Belgrade, Serbia
3 Sports Academy, University of Belgrade, Belgrade, Serbia
4 Department for Gynecology and Obstetrics, Clinical Center of Serbia; School of Medicine, University of Belgrad, Belgrade, Serbia
5 Department for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia; School of Medicine, University of Belgrade, Belgrade, Serbia
6 Institute for Epidemiology, School of Medicine, University of Belgrade, Belgrade, Serbia
*Correspondence: (M. TRISOVIC)
Clin. Exp. Obstet. Gynecol. 2019, 46(5), 776–778;
Published: 10 October 2019

Aim: Determining the prevalence of metabolic syndrome (MS) in the tested sample of pregnant women in the second and third trimesters of pregnancy, as well as the prognostic significance of MS in assessing the course and outcome of pregnancy. Materials and Methods: Prospective cohort study included 135 pregnant women after 24 0/7 weeks of pregnancy, hospitalized in the period from the January 1st, 2014 until September 30th, 2014. Data analysis included descriptive and analytical methods. Results: After assessment of possible confounding effect of age the authors confirmed that women with MS were 1,685-fold more likely give birth by caesarean section (OR = 1.685, p = 0.048), that it was a statistically significant prognostic factor in the earlier weeks of delivery (p = 0.001), and that it was statistically significant prognostic factor of lower Apgar scores in infants (p = 0.003). Conclusion: The early detection of MS during pregnancy reduces perinatal morbidity and is an important factor for the pregnancy outcome.

Metabolic syndrome
Cesarean section
Gestational diabetes
Gestational hypertension
Back to top